English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/94755
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV

AuthorsGarcía-Montojo, Marta; Fedetz, María; Alcina, Antonio; Matesanz, F.; Álvarez-Lafuente, Roberto
KeywordsMultiple sclerosis
Human endogenous retrovirus
HERV-W
Multiple sclerosis associated retrovirus
Chromosome x
Sex
Gender differences
Autoimmunity
Issue Date9-Jan-2014
PublisherBioMed Central
CitationRetrovirology 11(1): 2 (2014)
Abstract[Background] Multiple Sclerosis (MS) is an autoimmune demyelinating disease that occurs more frequently in women than in men. Multiple Sclerosis Associated Retrovirus (MSRV) is a member of HERV-W, a multicopy human endogenous retroviral family repeatedly implicated in MS pathogenesis. MSRV envelope protein is elevated in the serum of MS patients and induces inflammation and demyelination but, in spite of this pathogenic potential, its exact genomic origin and mechanism of generation are unknown. A possible link between the HERV-W copy on chromosome Xq22.3, that contains an almost complete open reading frame, and the gender differential prevalence in MS has been suggested.
[Results] MSRV transcription levels were higher in MS patients than in controls (U-Mann–Whitney; p = 0.004). Also, they were associated with the clinical forms (Spearman; p = 0.0003) and with the Multiple Sclerosis Severity Score (MSSS) (Spearman; p = 0.016). By mapping a 3 kb region in Xq22.3, including the HERV-W locus, we identified three polymorphisms: rs6622139 (T/C), rs6622140 (G/A) and rs1290413 (G/A). After genotyping 3127 individuals (1669 patients and 1458 controls) from two different Spanish cohorts, we found that in women rs6622139 T/C was associated with MS susceptibility: [χ2; p = 0.004; OR (95% CI) = 0.50 (0.31-0.81)] and severity, since CC women presented lower MSSS scores than CT (U-Mann–Whitney; p = 0.039) or TT patients (U-Mann–Whitney; p = 0.031). Concordantly with the susceptibility conferred in women, rs6622139*T was associated with higher MSRV expression (U-Mann–Whitney; p = 0.003).
[Conclusions] Our present work supports the hypothesis of a direct involvement of HERV-W/MSRV in MS pathogenesis, identifying a genetic marker on chromosome X that could be one of the causes underlying the gender differences in MS.
Publisher version (URL)http://dx.doi.org/10.1186/1742-4690-11-2
URIhttp://hdl.handle.net/10261/94755
DOI10.1186/1742-4690-11-2
ISSN1742-4690
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
1742-4690-11-2.xml95,97 kBXMLView/Open
1742-4690-11-2-S1.DOC49,5 kBMicrosoft WordView/Open
1742-4690-11-2.pdf635,68 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.